Patients with low tumor Cav-1 had significantly shorter cancer specific survival than patients with high tumor Cav-1 (10-year probability of event-free survival, P-EFS, was 20 ± 9.5% and 77 ± 3.5% in the two groups; Fig 3A). The gene discussed is CAV1; the disease is cancer.